ContraVir terminates licensing agreement for Chimerix drug

ContraVir Pharmaceuticals Inc., a pharmaceutical company headquartered in New Jersey, decided to terminate the license agreement between ContraVir and Chimerix dated Dec. 17, 2014. The termination of the agreement will be effective on June 1.

Read More